Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | BCL9 | O00512 | 1/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | THRA | P10827 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | TOP2A | P11388 | 2/20 | 0.38 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4077474 | 0.80 | KMT2A (0.54) | KMT2ASMN1; SMN2KDM4EMEN1RECQL | |
| SCHEMBL28915591 | 0.78 | POLM (0.51) | KMT2ASMN1; SMN2KDM4EMEN1RECQL | |
| SCHEMBL1013795 | 0.78 | KMT2A (0.58) | KMT2ASMN1; SMN2KDM4EMEN1RECQL | |
| SCHEMBL4076676 | 0.76 | KMT2A (0.47) | KMT2ASMN1; SMN2KDM4EMEN1RECQL | |
| SCHEMBL2538773 | 0.74 | GAA (0.58) | KMT2ASMN1; SMN2KDM4EMEN1RECQL | |
| SCHEMBL27988647 | 0.74 | ALDH1A1 (0.59) | KMT2ASMN1; SMN2KDM4EALDH1A1TDP1 | |
| SCHEMBL28897477 | 0.73 | KMT2A (0.42) | KMT2ASMN1; SMN2KDM4EMEN1RECQL | |
| SCHEMBL1625689 | 0.73 | GPR35 (0.47) | KMT2ASMN1; SMN2KDM4EMEN1RECQL | |
| SCHEMBL27528354 | 0.73 | KMT2A (0.47) | KMT2ASMN1; SMN2KDM4EMEN1RECQL | |
| SCHEMBL28423498 | 0.73 | JMJD7 (0.54) | KMT2ASMN1; SMN2KDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615233-B2 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2009-11-10 | — | — | US | disclosed |
| US-7527809-B2 | Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| EP-1113033-B1 | Polyhydroxyalkanoate | CANON KK (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-7393912-B2 | Polyhydroxyalkanoate containing amide group, sulfonic group, and sulfonate ester group, method for producing the same, and charge control agent, toner, image forming method, and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2008-07-01 | — | — | US | disclosed |
| US-7169598-B2 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2007-01-30 | — | — | US | disclosed |
| EP-1336635-B1 | Polyhydroxyalkanoate having amide group and sulfonic group, method of producing the same, charge controlling agent containing the polyhydroxyalkanoate, toner binder, toner, and image formation method and image forming apparatus using the toner | CANON KK (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-20060263432-A1 | Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response | CANON KABUSHIKI KAISHA (JP) | 2006-11-23 | — | — | US | disclosed |
| EP-1579277-B1 | POLYHYDROXYALKANOATE CONTAINING AMIDE GROUP, SULFONIC GROUP, AND SULFONATE ESTER GROUP, METHOD FOR PRODUCING THE SAME, AND CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KK (JP) | 2006-09-06 | — | — | EP | disclosed |
| US-7056708-B2 | Method of producing polyhydroxyalkanoate from alkane having residue containing aromatic ring in its molecule | CANON KABUSHIKI KAISHA (JP) | 2006-06-06 | — | — | US | disclosed |
| EP-1367078-B1 | Method of producing polyhydroxyalkanoate from alkane having residue containing aromatic ring in its molecule | CANON KK (JP) | 2006-04-19 | — | — | EP | disclosed |
| US-20030207412-A1 | Method of producing polyhydroxyalkanoate from alkane having residue containing aromatic ring in its molecule | CANON KABUSHIKI KAISHA (JP) | 2003-11-06 | — | — | US | disclosed |
| US-20030208029-A1 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2003-11-06 | — | — | US | disclosed |
| EP-1340777-A1 | Novel polyhydroxyalkanoate, method of producing the same, charge controlling agent containing polyhydroxyalkanoate, toner binder and toner, and image formation method and image forming apparatus using toner | CANON KABUSHIKI KAISHA (JP) | 2003-09-03 | — | — | EP | disclosed |
| EP-1336635-A1 | Polyhydroxyalkanoate having amide group and sulfonic group, method of producing the same, charge controlling agent containing the polyhydroxyalkanoate, toner binder, toner, and image formation method and image forming apparatus using the toner | CANON KABUSHIKI KAISHA (JP) | 2003-08-20 | — | — | EP | disclosed |
| US-20030073804-A1 | Polyhydroxyalkanoate, producing method therefor charge control agent containing such polyhydroxyalkanoate, toner containing such charge control agent and image forming method and image forming apparatus utilizing such toner | CANON KABUSHIKI KAISHA (JP) | 2003-04-17 | — | — | US | disclosed |
| US-6479621-B2 | PRODUCED BY MICROORGANISMS; BIODEGRADATION, BIOCOMPATIBILITY | CANON KABUSHIKI KAISHA (JP) | 2002-11-12 | — | — | US | disclosed |
| EP-1236754-A2 | Polyhydroxyalkanoate and method of producing same, and omega-(2-thienylsulfanyl) alkanoic acid and method of producing same | CANON KABUSHIKI KAISHA (JP) | 2002-09-04 | — | — | EP | disclosed |
| US-20020065389-A1 | Polyhydroxyalkanoate containing 3-hydroxythienylalkanoic acid as monomer unit and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2002-05-30 | — | — | US | disclosed |
| EP-1130043-A2 | Polyhydroxylalkanoate containing 3-hydroxythienylalkanoic acid as monomer unit and method for producing the same | CANON KABUSHIKI KAISHA (JP) | 2001-09-05 | — | — | EP | disclosed |
| EP-1113033-A2 | Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same | CANON KABUSHIKI KAISHA (JP) | 2001-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060263432-A1 | Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response | SKP1, HAMP, AUP1 | KMT2A 3735/4885SMN1; SMN2 3508/4885KDM4E 2061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.